Jubilant Ingrev. Q1 FY27 Results (NSE: JUBLINGREA)
Signal: Margin expansion
The read
Q1FY27 marks a strong start: revenue ₹1,300 Cr (+25% YoY), EBITDA margin 16.1% (+134bps YoY), PAT ₹106 Cr (+41% YoY) — all three segments reported growth, with Chemical Intermediates turning around sharply. Operating leverage from employee cost (up only 8.4%) was a key margin driver. Gross margin headwind from raw material costs remains a monitorable, but the company's ability to grow EBITDA 36.5% on 25% revenue growth shows improving earnings quality.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,300.27 Cr | 25.3% | 10.3% |
| EBIT | ₹158.29 Cr | 40.8% | |
| Net profit | ₹105.82 Cr | 40.9% | |
| EPS | ₹6.7 | 41.1% | |
| EBIT margin | 16.1% |
P&L walk
Revenue growth of 25% YoY was volume-led across all three segments; gross margin contracted 560bps YoY on raw material cost inflation, but operating leverage from employee cost (up only 8.4%) and a sharp turnaround in Chemical Intermediates drove EBITDA margin expansion of 134bps. PAT grew 41% YoY, aided by the absence of one-time labour code exceptional items.
Segments
Chemical Intermediates segment profit surged from ₹5 Cr (Q1FY26) to ₹44 Cr, driving group profitability; Nutrition profit grew 41% to ₹28 Cr; Specialty Chemicals profit grew modestly 2.7% to ₹109 Cr.
Key positives
- Revenue grew 25% YoY to ₹1,300 Cr, accelerating from Q4's 12% and Q1FY26's 1%.
- EBITDA margin expanded 134bps YoY to 16.1%, highest in at least 8 quarters.
- Operating leverage evident: employee cost grew only 8.4% vs revenue 25.3%.
- Chemical Intermediates segment profit jumped ~8x to ₹44 Cr, from near-zero a year ago.
- Nutrition & Health Solutions profit grew 41% YoY to ₹28 Cr.
- PAT grew 41% YoY, with clean earnings quality (no exceptional items this quarter).
Key concerns
- Gross margin contracted 560bps YoY to 51.7% due to raw material cost inflation (RM % of revenue 55.2% vs 43.2% year ago).
- Finance cost rose 38% YoY to ₹17.4 Cr, though debt/equity remains low at 0.22.
Research and educational content only. Not investment advice.